ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3Y7421
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Short Bowel Syndrome SBS Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2025

Code: QYRE-Auto-3Y7421
Report
August 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Takeda
Emmaus Medical
Ardelyx Inc
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma

Short Bowel Syndrome (SBS) Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Short Bowel Syndrome (SBS) Drugs Market

Short Bowel Syndrome (SBS) Drugs Market

The global market for Short Bowel Syndrome (SBS) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Short Bowel Syndrome (SBS) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Bowel Syndrome (SBS) Drugs.
The Short Bowel Syndrome (SBS) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Bowel Syndrome (SBS) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Bowel Syndrome (SBS) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.

Scope of Short Bowel Syndrome (SBS) Drugs Market Report

Report Metric Details
Report Name Short Bowel Syndrome (SBS) Drugs Market
CAGR 5%
Segment by Type
Segment by Sale Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Takeda, Emmaus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals, Zealand Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Short Bowel Syndrome (SBS) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Short Bowel Syndrome (SBS) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Short Bowel Syndrome (SBS) Drugs Market report?

Ans: The main players in the Short Bowel Syndrome (SBS) Drugs Market are Merck, Takeda, Emmaus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals, Zealand Pharma

What are the Type segmentation covered in the Short Bowel Syndrome (SBS) Drugs Market report?

Ans: The Types covered in the Short Bowel Syndrome (SBS) Drugs Market report are Glucagon-Like Peptide-2 (GLP-2), Growth Hormone, Glutamine, Other

Recommended Reports

Intestinal Disorder Drugs

Syndrome Pharmaceuticals

Gastro Urinary Treatments

1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Product Definition
1.2 Short Bowel Syndrome (SBS) Drugs by Type
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Short Bowel Syndrome (SBS) Drugs by Sale Channel
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2020-2031
1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2020-2031
1.4.3 Global Short Bowel Syndrome (SBS) Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
2.8 Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.8.1 Global Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
2.8.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short Bowel Syndrome (SBS) Drugs Market Scenario by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2031
3.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2020-2025
3.2.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Region: 2026-2031
3.3 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2031
3.3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020-2025
3.3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2026-2031
3.4 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.4.1 North America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.4.3 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.5.1 Europe Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.5.3 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.7.1 Latin America Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2031)
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2020-2025)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2026-2031)
4.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2031)
4.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2020-2025)
4.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2026-2031)
4.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2020-2031)
5 Segment by Sale Channel
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2031)
5.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2020-2025)
5.1.2 Global Short Bowel Syndrome (SBS) Drugs Sales by Sale Channel (2026-2031)
5.1.3 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2031)
5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2031)
5.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2020-2025)
5.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2026-2031)
5.2.3 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2031)
5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Emmaus Medical
6.3.1 Emmaus Medical Company Information
6.3.2 Emmaus Medical Description and Business Overview
6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.3.5 Emmaus Medical Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Company Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Company Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Company Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.7.1 OxThera Company Information
6.7.2 OxThera Description and Business Overview
6.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 Sancilio Pharmaceuticals
6.8.1 Sancilio Pharmaceuticals Company Information
6.8.2 Sancilio Pharmaceuticals Description and Business Overview
6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.9 Zealand Pharma
6.9.1 Zealand Pharma Company Information
6.9.2 Zealand Pharma Description and Business Overview
6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.9.5 Zealand Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short Bowel Syndrome (SBS) Drugs Industry Chain Analysis
7.2 Short Bowel Syndrome (SBS) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short Bowel Syndrome (SBS) Drugs Production Mode & Process Analysis
7.4 Short Bowel Syndrome (SBS) Drugs Sales and Marketing
7.4.1 Short Bowel Syndrome (SBS) Drugs Sales Channels
7.4.2 Short Bowel Syndrome (SBS) Drugs Distributors
7.5 Short Bowel Syndrome (SBS) Drugs Customer Analysis
8 Short Bowel Syndrome (SBS) Drugs Market Dynamics
8.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
8.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
8.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
8.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Takeda
Emmaus Medical
Ardelyx Inc
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
List of Tables
 Table 1. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
 Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Short Bowel Syndrome (SBS) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Short Bowel Syndrome (SBS) Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2020-2025)
 Table 61. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2026-2031)
 Table 62. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2020-2025)
 Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2026-2031)
 Table 64. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2020-2025)
 Table 65. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Sale Channel (2026-2031)
 Table 66. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2020-2025)
 Table 67. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2026-2031)
 Table 68. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2025)
 Table 69. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Merck Short Bowel Syndrome (SBS) Drugs Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Takeda Company Information
 Table 76. Takeda Description and Business Overview
 Table 77. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Takeda Short Bowel Syndrome (SBS) Drugs Product
 Table 79. Takeda Recent Developments/Updates
 Table 80. Emmaus Medical Company Information
 Table 81. Emmaus Medical Description and Business Overview
 Table 82. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product
 Table 84. Emmaus Medical Recent Developments/Updates
 Table 85. Ardelyx Company Information
 Table 86. Ardelyx Description and Business Overview
 Table 87. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Ardelyx Short Bowel Syndrome (SBS) Drugs Product
 Table 89. Ardelyx Recent Developments/Updates
 Table 90. Naia Pharmaceuticals Company Information
 Table 91. Naia Pharmaceuticals Description and Business Overview
 Table 92. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
 Table 94. Naia Pharmaceuticals Recent Developments/Updates
 Table 95. Nutrinia Company Information
 Table 96. Nutrinia Description and Business Overview
 Table 97. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Nutrinia Short Bowel Syndrome (SBS) Drugs Product
 Table 99. Nutrinia Recent Developments/Updates
 Table 100. OxThera Company Information
 Table 101. OxThera Description and Business Overview
 Table 102. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. OxThera Short Bowel Syndrome (SBS) Drugs Product
 Table 104. OxThera Recent Developments/Updates
 Table 105. Sancilio Pharmaceuticals Company Information
 Table 106. Sancilio Pharmaceuticals Description and Business Overview
 Table 107. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
 Table 109. Sancilio Pharmaceuticals Recent Developments/Updates
 Table 110. Zealand Pharma Company Information
 Table 111. Zealand Pharma Description and Business Overview
 Table 112. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product
 Table 114. Zealand Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Short Bowel Syndrome (SBS) Drugs Distributors List
 Table 118. Short Bowel Syndrome (SBS) Drugs Customers List
 Table 119. Short Bowel Syndrome (SBS) Drugs Market Trends
 Table 120. Short Bowel Syndrome (SBS) Drugs Market Drivers
 Table 121. Short Bowel Syndrome (SBS) Drugs Market Challenges
 Table 122. Short Bowel Syndrome (SBS) Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Short Bowel Syndrome (SBS) Drugs
 Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Short Bowel Syndrome (SBS) Drugs Market Share by Type: 2024 & 2031
 Figure 4. Glucagon-Like Peptide-2 (GLP-2) Product Picture
 Figure 5. Growth Hormone Product Picture
 Figure 6. Glutamine Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Short Bowel Syndrome (SBS) Drugs Market Value by Sale Channel (2020-2031) & (US$ Million)
 Figure 9. Global Short Bowel Syndrome (SBS) Drugs Market Share by Sale Channel: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Retail Pharmacies
 Figure 13. Global Short Bowel Syndrome (SBS) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Short Bowel Syndrome (SBS) Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Short Bowel Syndrome (SBS) Drugs Sales (2020-2031) & (K Pcs)
 Figure 16. Global Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Short Bowel Syndrome (SBS) Drugs Report Years Considered
 Figure 18. Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players: Market Share by Revenue in Short Bowel Syndrome (SBS) Drugs in 2024
 Figure 21. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2020-2031)
 Figure 57. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
 Figure 59. Global Revenue Market Share of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2020-2031)
 Figure 60. Global Short Bowel Syndrome (SBS) Drugs Price (USD/Pcs) by Sale Channel (2020-2031)
 Figure 61. Short Bowel Syndrome (SBS) Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Short Bowel Syndrome Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Short Bowel Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irritable Bowel Syndrome Drug Market Research Report 2024
Short Acting Contraceptives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030
Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Leigh Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diverticular Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irritable Bowel Syndrome Medication Market Research Report 2025
Bowel Irrigation Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Minimally Invasive Gastrointestinal Surgical System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bowel Preparation Drugs Market Research Report 2025
Small Intestinal Bacterial Overgrowth SIBO Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spinal Muscular Atrophy SMA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Serotonin Syndrome Treatment Market Research Report 2024
Global Prescription Gastrointestinal Drugs Market Research Report 2024
Antispasmodics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions